Carolyn Williamson
Molecular Biology · 2005–2021
A researcher in the Science corpus: 6 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 65 citations into it
- Genetics — 29 citations into it
- Virology — 19 citations into it
Whom Carolyn Williamson trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Carolyn Williamson overall
Papers from Carolyn Williamson's perspective
Ordered by how strongly the researchers Carolyn Williamson trusts endorse each paper. Same corpus, a different order for every researcher.
- Consequences of recombination on traditional phylogenetic analysis. (Genetics)
- Evaluation of methods for detecting recombination from DNA sequences: empirical data. (Molecular biology and evolution)
- Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar (medRxiv)
- Waning Immunity after the BNT162b2 Vaccine in Israel (New England Journal of Medicine)
- mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant (medRxiv)
- SARS-CoV-2 variants, spike mutations and immune escape
- MAFFT version 5: improvement in accuracy of multiple sequence alignment
- Codon-substitution models for heterogeneous selection pressure at amino acid sites. (Genetics)
- A coalescent-based method for detecting and estimating recombination from gene sequences. (Genetics)
- MrBayes 3: Bayesian phylogenetic inference under mixed models (Bioinform.)
Their papers
- RDP2: recombination detection and analysis from sequence alignments (2005) — 1,001 citations
- A Modified Bootscan Algorithm for Automated Identification of Recombinant Sequences and Recombination Breakpoints (2005) — 874 citations
- Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization (2021) — 1,070 citations
- Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa (2021) — 1,621 citations
- Detection of a SARS-CoV-2 variant of concern in South Africa (2021) — 1,497 citations
- Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies (2014) — 742 citations